| ¿µ¹® | fetal assessment | ÇÑ±Û | žƻçÁ¤ |
|---|---|---|---|
| ¼³¸í | ÀӽŠÁßÀ̳ª ºÐ¸¸ ÁßÀÇ Å¾ÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â °ÍÀ» žư¨½Ã¶ó°í ÇÑ´Ù. ¿©±â¿¡´Â ¿©·¯ °¡Áö ¹æ¹ýÀÌ Àִµ¥ Å©°Ô ºÐ¸¸Àü žư¨½Ã¿Í ºÐ¸¸Áß Å¾ư¨½Ã·Î Å©°Ô ³ª´«´Ù. 1. ºÐ¸¸Àüžư¨½Ã: ºÐ¸¸Çϱâ ÀÌÀüÀÇ Å¾ÆÀÇ »óŸ¦ °Ë»çÇÏ´Â ¹æ¹ýÀ¸·Î ´ÙÀ½°ú °°Àº ¿©·¯ °¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ¨ç ¾ç¼öõÀÚ: ÁÖ»ç±â¸¦ ÀÌ¿ëÇØ¼ »ê¸ðÀÇ ¹è¸¦ ÅëÇØ¼ ¾ç¼ö¸¦ ¾ò¾î¼ ºÐ¼®ÇÏ¿© žÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â ¹æ¹ý. ÀӽŠ15ÁÖ À̻󿡼 ½Ç½ÃÇÒ ¼ö ÀÖ´Ù. ¨è ÅÈÁÙõÀÚ: ÃÊÀ½ÆÄ°Ë»ç¸¦ ½Ç½ÃÇÏ¿© ¿µ»óÀ» º¸¸é¼ ÅÈÁÙ ¼Ó¿¡ ¹Ù´ÃÀ» ³Ö¾î¼ ±× °÷ÀÇ Ç÷°üÀ» ã¾Æ Ç÷¾×À» äÃëÇÏ¿© °Ë»çÇÏ´Â ¹æ¹ý. ¾ÆÁÖ À§ÇèÇÒ °Í °°Áö¸¸ »ó´çÈ÷ ¾ÈÀüÇÑ °ÍÀ¸·Î µÇ¾î ÀÖ´Ù. ´Ù¸¥ °Ë»ç¿¡ ºñÇØ¼ °Ë»ç¿¡ ¸¹Àº ±â¼úÀÌ ÇÊ¿äÇÏÁö¸¸ ¾ÆÁÖ ¸¹Àº Á¤º¸¸¦ Á¦°øÇØ ÁØ´Ù. ¨é ºñ½ºÆ®·¹½º°Ë»ç(nonstress test) : žƵµ Àڱà ¼Ó¿¡¼ ¿îµ¿À» ÇÑ´Ù. ±×¸®°í Á¤»óÀûÀ¸·Î žư¡ Àڱà ¼Ó¿¡¼ ¿îµ¿À» ÇÒ °æ¿ì¿¡´Â žÆÀÇ ½ÉÀå ¹Úµ¿ÀÌ »¡¶óÁö°Ô µÈ´Ù. žÆÀÇ ¿îµ¿°ú žÆÀÇ ½ÉÀå¹Úµ¿À» µ¿½Ã¿¡ °¨½ÃÇÏ¿© ¿îµ¿½Ã¿¡ žÆÀÇ ½ÉÀå¹Úµ¿ÀÌ »¡¶óÁö´Â °¡¸¦ ¾Ë¾Æº¸´Â °ÍÀÌ´Ù. |
||
| ¿µ¹® | health | ÇÑ±Û | °Ç° |
|---|---|---|---|
| ¼³¸í | ½ÅüÀû-Á¤½ÅÀûÀ¸·Î º´ÀÌ ¾ø´Â »óÅÂ. ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ ÇåÀå¿¡´Â ¡°°Ç°À̶õ Áúº´ÀÌ ¾ø°Å³ª Çã¾àÇÏÁö ¾ÊÀº °Í¸¸ ¸»ÇÏ´Â °ÍÀÌ ¾Æ´Ï¶ó ½ÅüÀû-Á¤½ÅÀû-»çȸÀûÀ¸·Î ¿ÏÀüÈ÷ ¾È³çÇÑ »óÅ¿¡ ³õ¿© ÀÖ´Â °Í¡±À̶ó°í Á¤ÀÇÇϰí ÀÖ´Ù. »ç¶÷Àº ÀÎÁ¾-Á¾±³-Á¤Ä¡-°æÁ¦-»çȸÀÇ »óÅ ¿©Çϸ¦ ºÒ¹®ÇÏ°í °íµµÀÇ °Ç°À» ´©¸± ±Ç¸®°¡ ÀÖ´Ù´Â °ÍÀ» ¸í½ÃÇÑ °ÍÀÌ´Ù. Áï °ú°Å¿¡´Â, °Ç°À̶õ À°Ã¼Àû-Á¤½ÅÀûÀ¸·Î Áúº´À̳ª ÀÌ»óÀÌ ¾ø°í, °³ÀÎÀûÀ¸·Î Á¤»óÀûÀÎ »ýȰÀ» ¿µÀ§ÇÒ ¼ö ÀÖ´Â ½Åü»óŸ¦ ¸»ÇÏ¿´À¸³ª, ¿À´Ã³¯¿¡´Â °³ÀÎÀÌ »çȸ»ýȰ¿¡ ÀÇÁ¸ÇÏ´Â °æÇâÀÌ Ä¿Áü¿¡ µû¶ó¼ »çȸ°¡ °¢ °³ÀÎÀÇ °Ç°¿¡ ±â´ëÇÏ´Â °Íµµ ¸¹¾ÆÁ³±â ¶§¹®¿¡ »çȸÀûÀÎ °Ç°À̶õ ¸é¿¡¼ ÀÌ¿Í °°Àº Á¤Àǰ¡ »ý°Ü³ °ÍÀ¸·Î º¸ÀδÙ. Çѱ¹ÀÇ Çå¹ý¿¡´Â °Ç°À» ¡°¸ðµç ±¹¹ÎÀÌ ¸¶¶¥È÷ ´©·Á¾ß ÇÒ ±âº»ÀûÀÎ ±Ç¸®¡±¶ó°í ±ÔÁ¤Çϰí ÀÖ¾î °Ç°À» ÇϳªÀÇ ±âº»±ÇÀû °³³äÀ¸·Î º¸°í ÀÖ´Ù. ¶ÇÇÑ Áúº´ÀÌ ¾ø´Â »óŶó´Â ¼öµ¿Àû °Ç°¿¡ ´ëÇÑ Åµµ¿¡¼, ±ÝÁÖ-±Ý¿¬ µî »ýȰ½À°üÀÇ º¯È³ª ¿îµ¿ °°Àº Àû±ØÀûÀ¸·Î °Ç°ÇØÁö·Á´Â ³ë·Â µî ´Éµ¿Àû ŵµ°¡ °Á¶µÇ°í ÀÖ´Ù. °Ç°ÀÇ ±¸Ã¼Àû ¿ä¼Ò·Î´Â À°Ã¼ÀûÀÎ ÇüÅÂÀû ¿ä¼Ò(½ÅÀå-üÁß°ú °°Àº ¿ÜÇüÀû °èÃø°ªÀ̳ª ³»ÀåÀÇ ¿©·¯ ±â°ü µî)¿Í ±â´ÉÀû ¿ä¼Ò(¿©·¯ ±â°üÀÇ »ý¸®±â´ÉÀ̳ª Á¾ÇÕÀûÀΠü·Â µî), Á¤½Å±â´ÉÀû ¿ä¼Ò·Î ºÐ·ùÇÏ¿© Æò°¡Çϱ⵵ ÇÑ´Ù. |
||
| ¿µ¹® | public health | ÇÑ±Û | °øÁߺ¸°Ç |
|---|---|---|---|
| ¼³¸í | Áý´ÜÀ̳ª Áö¿ª»çȸÀÇ °Ç°À» ¿¬±¸ÇÏ´Â ¿¹¹æÀÇÇÐ. 18¼¼±â Áß¿±ºÎÅÍ »ê¾÷Çõ¸í¿¡ ÀÇÇØ Àα¸°¡ µµ½Ã·Î ÁýÁßµÇ°í »ýȰȯ°æÀÌ ¿¾ÇȵǾî ÄÝ·¹¶ó³ª °áÇÙ µîÀÌ À¯ÇàÇ߱⠶§¹®¿¡ ±× ´ëÃ¥À¸·Î ź»ýÇÏ°Ô µÇ¾ú´Ù. ¿ì¸® ³ª¶ó¿¡¼´Â ±¤º¹ ÈĺÎÅÍ º¸°Ç¼ÒÀÇ ¼³Ä¡³ª ´ëÇÐÀÇ °Á ½Å¼³ µî ±Ù´ëÀûÀÎ °øµ¿º¸°ÇÇàÁ¤ÀÌ ÀÌ·ç¾îÁö°Ô µÇ¾ú´Ù. ÀÌ ¶§±îÁö´Â ÀÏÁ¦ ½Ä¹Î´ç±¹ÀÇ °æÂû·Â¿¡ ÀÇÇÑ ¸í·É°ú ´Ü¼ÓÀ¸·Î ½ÃÁ¾ ÇØ¿Ô´Ù. ÇöÀçµµ ¿ì¸®³ª¶óÀÇ µµ½Ã ȯ°æ Á¤ºñ°¡ À¯·´ ¿©·¯ ³ª¶ó³ª ¹Ì±¹¿¡ ºñÇØ µÚÁø °ÍÀº ÀÌ·¯ÇÑ ¿µÇâ ¶§¹®ÀÌ´Ù. ÃÖ±Ù¿¡´Â °øÁߺ¸°ÇÀÇ ÁÖµÈ ¸ñÀûÀÌ Àü¿°º´ ´ëÃ¥¿¡¼ ¾Ï-³úÁßdz-½ÉÀ庴-´ç´¢º´ µî »ýȰ½À°üº´ ´ëÃ¥À¸·Î ¿Å°ÜÁö°í ÀÖ´Ù. |
||
| ¿µ¹® | industrial health | ÇÑ±Û | »ê¾÷º¸°Ç |
|---|---|---|---|
| ¼³¸í | ±â¾÷ü´Â ±Ù·ÎÀÚÀÇ »ý¸í°ú °Ç°¿¡ ´ëÇÑ ¾ÈÀüÀ§»ý°ü¸®Ã¼Á¦°¡ ±â¾÷ÀÇ Á¾·ù¿Í ±Ô¸ð¿¡ »óÀÀÇÏ°Ô Àǹ«ÈÇÒ Çʿ䰡 ÀÖ´Ù. »ê¾÷º¸°ÇÀ̶õ ÀÌ·¯ÇÑ ³ëµ¿À§»ý¹®Á¦ÀÇ °³³äÀ» ´õ¿í Æø³Ð°Ô È®´ëÇÏ°í Æ¯È÷ ±Ù·ÎÀÚÀÇ °Ç°À» ÃËÁø½Ã۰í ÀçÇØ¸¦ ¿¹¹æÇѴٰųª ÄèÀûÇÑ ±Ù·Îȯ°æÀ» Á¶¼ºÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â °ÍÀÌ´Ù. |
||
| COOHTA | Canadian Coordinating Office for Health Technology Assessment |
|---|---|
| HCTA | health care technology assessment |
| HSTAR | health services and technology assessment research |
| HSTAT | health services/technology assessment text |
| OHTA | Office of Health Technology Assessment |
| HTA | Health Technology Assessment |
|---|---|
| T.A. | Technology Assessment |
| OTA | of Technology Assessment |
| C-HAQ | Childhood Health Assessment Questionnaire |
| CAHPS | Consumer Assessment of Health Plan Study |
| technology assessment, biomedical | Evaluation of biomedical technology in relation to cost, efficacy, utilization, etc., and its future impact on social, ethical, and legal systems. (12 Dec 1998) |
|---|---|
| united states office of technology assessment | An office established to help congress participate and plan for the consequences of uses of technology. It provides information on both the beneficial and adverse effects of technological applications. (12 Dec 1998) |
| annual reports | Annual statements concerning the administrative and operational functions of an institution or organization. (12 Dec 1998) |
| health risk assessment | Method of describing an individual's chance of falling ill or dying of a specified condition, based on actuarial calculations that allow for known exposure to risk; expressed as expected age at which death or disease will occur, and intended as a way of drawing an individual's attention to the probable consequences of risk behaviour. (05 Mar 2000) |
| national centre for health care technology | A centre in the public health service which coordinates and administers a program of research, demonstrations, and evaluations of medical technologies and assessments of health care technology. (12 Dec 1998) |
| antibody technology | <molecular biology> Techniques for the synthesis of polyclonal and monoclonal antibodies for use in research, diagnostics and therapeutics. (09 Feb 1998) |
| assessment | Appraisal. (05 Mar 2000) |
| assisted reproductive technology | Originally, a range of techniques for manipulating eggs and sperm in order to overcome infertility. Encompasses drug treatments to stimulate ovulation; surgical methods for removing eggs (e.g., laparoscopy and ultrasound-guided transvaginal aspiration) and for reimplanting embryos (e.g., zygot intrafallopian transfer (or ZIFT); in vitro and in vivo fertilization (e.g., artificial insemination and gamete intrafallopian transfer (or GIFT); ex utero and in utero foetal surgery; as well as laboratory regimes for freezing and screening sperm and embryos, and micromanipulating and cloning embryos. The field's first major success came in 1978 with the birth of "test-tube baby" Louise Brown, engineered by Steptoe, Edwards, et al., of England. As the technologies spread, they increasingly are being employed for purposes beyond infertility, i.e., to reduce the risk of, or avoid passing on, hereditary disease and to select for infant sex. Further uses that would aim at improving the "quality" of offspring have been widely discussed and raise profound legal and ethical questions. See: eugenics. (05 Mar 2000) |
| biological assessment | A specific process required as part of an environmental assessment. An evaluation of potential effects of a proposed project on proposed, endangered, threatened, and sensitive animal and plant species and their habitats. (05 Dec 1998) |
| Brazelton's Neonatal Behavioural Assessment Scale | A scale used by obstetricians, paediatricians, and paediatric psychologists to assess the sensory, motor, emotional and physical development of the neonate, usually beginning at birth or in the first month of life. (05 Mar 2000) |
| recombinant DNA technology | A series of procedures used to join together (recombine) DNA segments. A recombinant DNA molecule is constructed (recombined) from segments from 2 or more different DNA molecules. Under certain conditions, a recombinant DNA molecule can enter a cell and replicate there, autonomously (on its own) or after it has become integrated into a chromosome. (12 Dec 1998) |
| geriatric assessment | Evaluation of the level of physical, physiological, or mental functioning in the older population group. (12 Dec 1998) |
| personality assessment | The determination and evaluation of personality attributes by interviews, observations, tests, or scales. Articles concerning personality measurement are considered to be within scope of this term. (12 Dec 1998) |
| risk assessment | The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (12 Dec 1998) |
| process assessment | An evaluation procedure that focuses on how care is delivered, based on the premise that there are standards of performance for activities undertaken in delivering patient care, in which the specific actions taken, events occurring, and human interactions are compared with accepted standards. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|